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Abstract 
 
Introduction: Traditional automatic dishwashing tablets are contained within an external 
wrapper that requires removal prior to use.  
Objective: To determine the toxicity of traditional tablets and to compare this with our 
previously reported experience of soluble film dishwashing tablets.  
Methods: Telephone enquiries regarding traditional tablets were analysed retrospectively for 
the period January 2008 to December 2015. 
Results: Traditional tablets. There were 503 enquiries relating to 492 patients who had 
been exposed to a traditional tablet. Most involved children aged 5 years or less (87.4%). 
The majority (78.6%) of patients did not develop symptoms after exposure; 21.1% developed 
minor (PSS 1) symptoms while one patient developed moderate features. Exposure 
occurred predominantly as a result of ingestion (n=476, 96.7%); the most common feature in 
symptomatic patients (n=99, 20.8%) was vomiting (70 [14.7%] cases). Significantly 
(p<0.0001) more adults (44.9% of 49 adults; 95% CI = 31.9-58.7) were reported with 
features than children (18.2% of 434; 95% CI = 14.9-22.1). There were five cases of eye 
contact which resulted in eye pain in two patients and eye irritation in another. Only one of 
11 patients exposed dermally developed features (a rash around the mouth).  
Comparison with soluble film exposures: The percentage of patients that were reported 
with clinical symptoms following ingestion of a soluble film dishwashing tablet (31.7% of 473 
patients; 95% CI = 27.7-36.0) was significantly greater (p<0.0001) than that for traditional 
tablet (20.9% of 483 patients; 95% CI = 17.5-24.8). Vomiting was the most commonly 
reported feature and occurred significantly (p<0.0001) more frequently amongst patients 
who had ingested a soluble film tablet (25.5%; 95% CI = 21.8-29.6) than a traditional tablet 
(14.7%; 95% CI = 11.8-18.1). 
Conclusions: Exposure to both traditional and soluble film tablets only rarely produced 
clinically significant symptoms (PSS ≥ 2). However, ingestion of a soluble film tablet was 
significantly more likely to result in clinical features than ingestion of a traditional tablet.   
  
 
 
Introduction 
Traditional tablets* for automatic dishwashing machines are contained within an 
external wrapper that requires removal prior to loading the enclosed tablet into the 
machine. These tablets are still used commonly worldwide. There have been few 
reports on the toxicity of traditional automatic dishwashing detergents; [1,2,3,4] the 
most recent report was published 20 years ago and the composition of these older 
products was different from the current tablets. Some 10 years ago automatic 
dishwashing tablets* contained within a soluble film became available in the United 
Kingdom (UK) and are now marketed in many European countries and in North 
America. We have previously published data on 488 exposures involving soluble film 
automatic dishwashing tablets. [5]  
Soluble films used in this way are claimed to have two main advantages. 
Firstly, the exact amount of chemicals recommended for the product’s intended 
purpose is delivered once the film dissolves completely in water. Secondly, as there 
is avoidance of direct contact with the chemicals, products were promoted to 
improve safety. That being said, the integrity of the soluble film can be compromised 
and the contents of the tablet can be released prematurely when in contact with 
moist hands or saliva. [5] 
The traditional (wrapper covered) type of tablet consists entirely of a 
compressed powder, whereas soluble film tablets can also contain liquid and/or gel 
components. That said, the chemical composition of traditional and soluble film 
dishwashing tablets is similar. Both types of tablet contain a source of hydrogen 
peroxide (often as sodium percarbonate ≤ 20%) and non-ionic surfactants ≤ 5%. 
Other constituents in some formulations include sodium carbonate ≤ 30%, sodium 
tripolyphosphate ≤ 50%, and sodium silicate ≤ 10%, which reduce water hardness. 
The tablets have a resulting alkaline pH (generally between 9 and 11 when dissolved 
in water).  
 
*Tablet is a generic name for the products which, up to a few years ago, largely 
comprised of compressed powder using the tableting technique. It in fact is a pars 
pro toto employed by Industry for these products which now include soluble film 
products.  
 
 
 
As the chemical composition of present day traditional tablets is similar to 
those enclosed in a soluble film, it would not be anticipated that the toxicity of 
traditional tablets as reported to the United Kingdom (UK) National Poisons 
Information Service (NPIS) over the period 2008-2015 would be different from that 
which we have reported for soluble film automatic dishwashing tablets over the same 
period. [5] Nonetheless, as the toxicity of present day automatic dishwashing tablets 
has not been ascertained previously, we have investigated the reported toxicity of 
these tablets and ascertained whether or not they are more likely to result in clinically 
important features than those enclosed in a soluble film. In addition, we have 
compared the toxicity reported in children and adults with both types of tablet. 
 
Methods 
The UK NPIS (www.npis.org) provides information and evidence-based 
management advice about individual substances through its online database 
TOXBASE® and its 24-hour telephone advice service, staffed by information 
scientists and supported by a rota of consultant clinical toxicologists. The UK NPIS 
takes telephone enquiries from NHS healthcare professionals. 
A retrospective analysis of telephone enquiries to the UK NPIS from across 
the UK regarding automatic dishwashing tablets was undertaken for the period 
1 January 2008 to 31 December 2015. The NPIS UKPID (United Kingdom Poisons 
Information Database) central database was searched for enquiries involving all 
types of automatic dishwashing products and each exposure to a tablet was 
categorized as being of the traditional or soluble film type. The data relating to the 
traditional type of tablets were analyzed and their toxicity then compared to that of 
soluble film tablets. [5] Confidence intervals were calculated and a two-sample Chi-
squared test was performed using GraphPad Prism Version 7.01 to determine 
whether there were significant differences between exposures to traditional and 
soluble film tablets and between children and adults. 
Enquiries received from outside the UK were excluded from this study. Data 
(both from the text narrative as well as discrete data fields) extracted from the 
enquiries included: age of patient; route(s) of exposure; source of enquiry; location 
where exposure occurred; circumstances of exposure; product information; features 
reported at the time of enquiry and the assigned World Health Organisation 
 
 
/International Programme on Chemical Safety /European Commission /European 
Association of Poison Centres and Clinical Toxicologists (WHO/IPCS/EC/EAPCCT) 
Poisoning Severity Score (PSS). [6] Data on composition were obtained from the 
NPIS Product Data Centre which contains safety datasheets (SDS) on products 
marketed in the UK. 
This study did not require approval by a UK Research Ethics Committee as 
the UK Health Research Authority has declared that ethical approval is not needed 
for research studies that use information collected routinely in any UK administration 
(England, Wales, Scotland, Northern Ireland) as part of usual clinical care, provided 
this information is passed to the researchers in a fully anonymised format. 
 
Results 
There were 1290 enquiries (1266 exposures) involving automatic dishwashing 
tablets over the period of 2008 to 2015. There were 503 enquiries (492 exposures) 
about the traditional type, 498 enquiries (488 exposures) about the soluble film type 
and 289 enquiries (286 exposures) regarding an automatic dishwashing tablet which 
could not be identified due to incomplete information relating to the product being 
available to the enquirer.  
 
Traditional tablets 
Over half of 503 enquiries (n=266, 52.9%) were received from NHS (National Health 
Service) Direct and NHS 24 [Scotland]. NHS Direct closed on March 31 2014 in 
England (though not in Wales) and was replaced by NHS 111. These services 
provide the public with advice on health issues. Enquiries from general practices, 
including out-of-hours services (n=146; 29.0%), hospitals (n=65; 12.9%), ambulance 
services (n=24, 4.8%) and walk-in centres (n=2, 0.4%) accounted for the remainder 
of the enquiries.  
The majority (n=440, 89.4%) of the 492 exposures involved children 
(<18 years); most were aged 5 years or less (n=430, 87.4%) but there were also two 
cases where the age of the child was not known. Of the remaining 52 adult cases, 
the adult age group most frequently reported to have been exposed to traditional 
dishwashing tablets were those aged 70 years or greater (n=19, 36.5%). In two adult 
exposures cases, the exact patient age was not known.  
 
 
Exposure occurred at home in the majority of cases (n=483, 98.2%). The 
other nine cases (1.8%) occurred in a nursing/care home. 
Ingestion alone accounted for most exposures (n=476, 96.7%). There were 
11 other cases of ingestion which also involved other exposure routes, most 
commonly skin contact (n=10, 2.0%); the eye was also involved in one case (0.2%). 
The remaining 5 cases comprised eye contact alone (n=4, 0.8%) and skin contact 
alone (n=1, 0.2%). 
Information was available to permit product identification and, therefore, 
determination of the composition in 411 of the 492 cases (83.5%) (Table 1).  
A Poisoning Severity Score (PSS) was calculated at the time of the telephone 
enquiry in 487 (99.0%) of the 492 exposures (Table 2); insufficient details were given 
in the remaining 5 cases to determine the PSS. Most patients (n=383; 78.6%) had 
not developed any symptoms (PSS 0) at the time the enquiry was made. One 
hundred and three patients (21.1%) developed minor symptoms (PSS 1), and the 
remaining case was graded as moderate (PSS 2) toxicity due to prolonged vomiting 
for over 24 hours. There were no reports of any patient developing severe features 
of toxicity (PSS 3), nor were there any reported deaths. 
 
Ingestion 
Four hundred and eighty-seven patients were reported to have been exposed to 
some part of a tablet by ingestion (either alone or with eye or skin contact). The 
majority of the 487 cases of ingestion occurred in children (n=438, 89.9%) and 
predominantly involved those aged 5 years or less (n=429, 97.9%). Of the 438 
pediatric (<18 years) exposures, 18.2% (n=79) of children developed features (in 4 
cases the features were not known). Vomiting (n=63) was the most commonly 
reported feature followed by nausea (n=4), coughing (n=4) or skin rash (n=4) but 
various other features including diarrhea, foaming at the mouth and increased 
salivation were reported (Table 3).  
Forty-eight of 438 children were reported to have ingested at least half a 
tablet (35.4% developed features), 264 ingested a small amount of a tablet (14.4% 
developed features) and 46 children ingested only tablet residue (15.2% developed 
features). The amount of tablet ingested was unknown in the remaining 80 cases, of 
whom 21.3% developed features.  
 
 
Of the 49 adults, 22 (44.9%; 95% CI = 31.9-58.7) were reported to have 
developed features. Hence, among this cohort of traditional tablet exposures 
reported to the UK NPIS, significantly more (p<0.0001) adults developed features 
than children (18.2%; 95% CI = 14.9-22.1). Eight of these 49 adults had a history of 
dementia, 8 of learning difficulties, 1 a psychiatric history of ingesting items for self-
harm; 6 occurred within a nursing or care home (although no medical history was 
provided for these patients) and 5 were aged 80 years or above. Fourteen of these 
28 patients had reportedly eaten between three quarters of a tablet and up to two 
tablets and features developed in 11 of these 28 patients (39.3%).  
In 9 other cases, patients had accidentally ingested residue from crockery in 9 
separate incidents; this had been left due to a fault with the dishwashing machine 
following the washing cycle. Five of these 9 patients (55.6%) developed features. 
 There were 3 cases of substantial ingestion: one (a 22-year-old) had ingested 
11 dishwashing tablets and developed pharyngitis and a skin rash; the second (a 36-
year-old) had been eating dishwashing tablets for the previous 12 months and 
reported abdominal pain; the third patient (a 92-year-old) had ingested 4 tablets over 
the course of 2 hours but remained well. 
In 4 of the 487 cases involving ingestion, a PSS could not be assigned 
because of insufficient clinical data; all 4 were pediatric cases. Three hundred and 
eighty-two of the remaining 483 (79.1%) exposures cases were graded as PSS 0 
(asymptomatic). Minor features of toxicity developed in 100 patients (20.7%) and 
moderate features in only one patient (0.2%). A comprehensive list of the features 
that developed following ingestion is shown in Table 3.  
 
Eye exposure 
There were 5 cases of eye contact. In one case (involving an adult) the features 
were unknown and a PSS could not be assigned. Of the remaining 4 cases 
(Table 4), 2 patients (aged 70 and 72 years of age) reported eye pain, 1 patient 
developed eye irritation (a 2-year-old child) and the fourth case involved a baby of 10 
months who was thought to have been exposed by ingestion and eye contact; the 
child remained well.  
 
Dermal exposure 
 
 
Eleven cases involved dermal contact; all but one case also involved ingestion. All of 
the 11 were children aged 4 years or less and only one child developed dermal 
features (a rash around the mouth).  
 
Traditional tablet exposures versus soluble film tablet exposures 
The WHO/IPCS/EC/EAPCCT Poisoning Severity Scores (PSS) for both traditional 
and soluble film types of tablet exposure are shown in Table 2. A significantly 
(p<0.0001) greater proportion of those exposed to a traditional tablet were 
asymptomatic (n=383; 78.6%; 95% CI = 74.8-82.1), compared with those exposed to 
a soluble film tablet (n=325; 67.4%; 95% CI = 63.1-71.5).  
The percentage of children (<18 years) exposed by ingestion to traditional 
tablets (n=438; 89.9%; 95% CI = 86.9-92.3) was significantly lower (p<0.0001) than 
the percentage of ingestions involving soluble film tablets (n=464; 96.9%; 95% CI = 
94.9-98.1). In the case of ingestions involving children aged 5 years or less, the 
percentage amongst the traditional tablet group (n=429; 88.1%; 95% CI = 84.9-90.7) 
was significantly lower (p=0.0009), compared to the percentage for the soluble film 
group (n=451; 94.2%; 95% CI = 91.7-95.9). Conversely, a significantly higher 
(p=0.0001) percentage of adults ingested a traditional tablet (n=49; 10.1%; 95% CI = 
7.7-13.1) than a soluble film tablet (n=15; 3.1%; 95% CI = 1.9-5.1).  
The overall percentage of patients that became symptomatic following 
ingestion of a traditional tablet (20.9% of 483 patients; 95% CI = 17.5-24.8) was 
significantly lower (p=0.0001) than that for soluble film tablets (31.7 % of 473 
patients; 95% CI = 27.7-36.0). Significantly (p<0.0001) fewer children (<18 years) 
developed features following ingestion of a traditional tablet type (18.2% of 434 
patients; 95% CI = 14.9-22.1) compared to children who had eaten a soluble film 
tablet (32.1% of 461 patients; 95% CI = 28.0-36.5). However, the percentage of 
adults that became symptomatic following ingestion of a traditional tablet (44.9% of 
49 patients) was higher when compared with those that ingested a soluble film tablet 
(16.7% of 12 patients), but this difference was not statistically significant.  
Vomiting was the most commonly reported feature irrespective of the tablet 
type (Table 3) and occurred significantly (p<0.0001) more frequently amongst 
patients that had ingested a soluble film tablet (25.5%; 95% CI = 21.8-29.6) than a 
traditional tablet (14.7%; 95% CI = 11.8-18.1). Interestingly, vomiting was not 
 
 
reported in adults following ingestion of a soluble film tablet, whereas it occurred in 8 
of 49 patients who ingested a traditional tablet (non-significant difference). 
 Ocular toxicity developed in a similar proportion of patients (non-significant 
difference) exposed to traditional (75.0% of 4 cases; 95% CI = 30.1-98.7) and 
soluble film tablets (70.0% of 10 cases; 95% CI = 39.7-89.2). Eye pain was reported 
by 2 patients from each group, though conjunctivitis or blurred vision was only 
reported by those exposed to a soluble film tablet (Table 4). Eye irritation developed 
in one patient exposed to a traditional tablet.  
 Dermal exposure involved a traditional tablet in 11 instances and a soluble 
film tablet in 8. All 19 cases involved children (all but one child was ≤ 2 years) and 18 
also involved ingestion. Only one patient was reported to have developed dermal 
features (a skin rash around the mouth) following contact with a traditional tablet.  
 
Toxicity of unknown group of tablet exposures 
We did not consider it appropriate to analyze all the data on the 286 exposures 
where the precise identity of the tablet was not known, as this could introduce 
substantial bias. We have included data on the PSS of these patients in Table 2, 
which indicates that in all probability this unknown group consists of roughly equal 
numbers of exposures to both types of tablets. 
 
Discussion 
Our study shows that the ingestion of traditional automatic dishwashing tablets 
resulted only rarely in moderate (PSS 2) toxicity. Features occurred in 20.9% of all 
ingestions; only 1 of 483 patients developed moderate features of toxicity. Vomiting 
was the only consequence in the majority (14.7% of all cases; 70.3% of those 
symptomatic). This is surprising given the potential for toxicity of the major active 
ingredients, sodium percarbonate (a source of hydrogen peroxide) and non-ionic 
surfactants, and of sodium carbonate, sodium tripolyphosphate and sodium silicate 
present in some products to reduce water hardness. 
Toxicity from hydrogen peroxide occurs as a result of its corrosive effects and 
release of oxygen causing embolism. [7] Ingestion of hydrogen peroxide may cause 
irritation of the gastrointestinal tract with nausea, vomiting, foaming at the mouth and 
hematemesis. [8] The foam may then obstruct the respiratory tract [9] or result in 
 
 
pulmonary aspiration. As the estimated maximal amount of hydrogen peroxide 
liberated from a typical dishwashing tablet (all the powder swallowed, completely 
dissolved and hydrogen peroxide fully released) is less than 1.3 g, it would not be 
anticipated that the more severe features reported after exposure to high strength 
hydrogen peroxide solutions would occur, unless several tablets were ingested 
deliberately. In our study nausea and vomiting, foaming at the mouth, blistering in 
the mouth, burning sensation in the mouth, painful swallowing, burns on lip and 
tongue, ulcer on lip, swollen lips, abdominal pain, laryngitis, and pharyngitis could 
have been hydrogen peroxide-induced. 
Sodium carbonate ingestion in humans has led to stridor, drooling, coughing, 
and oedematous lips. [10] Hence, coughing and swollen lips in our study might have 
developed in part due to sodium carbonate.  
While ophthalmic damage can be caused by non-ionic surfactants, [11] other 
experimental studies [12] have shown that sodium carbonate causes conjunctivitis, 
corneal opacities and chronic superficial keratitis. Sodium silicate has also been 
shown to cause conjunctivitis, iritis and corneal opacity experimentally, [13] but is 
unlikely to do so at the concentrations present in most tablets. Thus, eye pain and 
eye irritation reported in our study could have been caused by non-ionic surfactants 
and/or sodium carbonate and/or sodium silicate.  
Dermal exposure from sodium tripolyphosphate and sodium carbonate has 
resulted in erythema and oedema and a severe vesicular reaction on abraded skin; 
[14] sodium silicate is non-irritating to the skin at the concentration usually present in 
the tablets. [13] Only one patient developed a rash following dermal contact in our 
series. 
We compared these results with those we published recently on soluble film 
automatic dishwashing tablets. [5] Overall, there were a similar number of cases 
involving ingestion of a dishwashing tablet reported for the traditional (n=488) and 
the soluble film types (n=479). The percentage of children (<18 years) exposed by 
ingestion to traditional tablets (89.9%) was significantly lower (p<0.0001) than the 
percentage of children ingesting soluble film tablets (96.9%). This was true also of 
ingestions involving children aged 5 years or less (88.1% vs. 94.2%; p=0.0009), 
which may relate to the appearance of the soluble film tablets. 
 
 
Conversely, a significantly higher (p<0.0001) percentage of adults ingested a 
traditional tablet (10.1%) than a soluble film tablet (3.1%), presumably reflecting use 
and availability. The percentage of patients that became symptomatic following 
ingestion of a traditional tablet (20.9%) was significantly lower (p<0.0001) than that 
for soluble film tablets (31.7%). Furthermore, significantly more (p<0.0001) adults 
developed features than children after traditional tablet ingestion. 
Cases involving eye exposure to traditional tablets (n=5) were fewer than 
those to soluble film tablets (n=10) whereas the number of dermal exposures was 
similar (n=11 vs. n=8, for traditional and soluble film tablets, respectively). However, 
the number of cases for these exposure routes was small precluding meaningful 
interpretation. 
What are the potential reasons for these results? Our understanding is that 
the hardness of the traditional tablets was set so that a young child could not easily 
bite a chunk off. We believe adults are more likely than young children to be able to 
bite into a hard tablet and consume the powder. In contrast, soluble film tablets have 
a loose powder held together by the external wrapper. As a consequence, it is 
possible that the disintegration of a soluble film tablet may result in a larger dose of 
ingredients being involved in the exposure. Moreover, some soluble film products 
have a liquid component which may be ingested more easily compared to the 
powder-only products. We are not aware of any data on the public's risk perceptions 
of the two forms of tablet. We find these explanations for these apparent differences 
more convincing than reporting bias, but this cannot be excluded.  
Vomiting was the most commonly reported feature irrespective of the type of 
tablet and occurred significantly (p<0.0001) more frequently amongst patients who 
had ingested a soluble film tablet (25.5%) than a traditional tablet (14.7%). The 
possible reasons are explained above, though it should be stressed that the majority 
(traditional 79.1%; soluble film 68.3%) of patients who ingested either type of tablet 
remained asymptomatic and when symptoms developed they were of a minor kind. 
 Historically, automatic dishwashing products were formulated as liquids, 
powders or granules and had different compositions from those marketed today, 
which must be recognized when interpreting the previously published literature. Our 
study related to present day traditional tablets rather than these older formulations. 
Krenzelok [2] reported the outcome in 192 exposures involving a liquid automatic 
 
 
dishwashing detergent. 99.3% of 146 ingestions either did not result in features 
(n=133) or only minor features (n=12). In contrast, 91.3% of 23 patients exposed 
ophthalmically developed mild or moderate symptoms; conjunctivitis and corneal 
lesions were reported most commonly but no patient had permanent sequelae. In 
another series, [3] 12 of 18 children were admitted to hospital after exposure to an 
automatic dishwashing product (granular form). Features included crying, drooling, 
vomiting, coughing and stridor in combination with oropharyngeal burns. Fourteen of 
the 18 children underwent endoscopy and 11 had evidence of oesophageal injury. 
In a third study, [4] 3 of 61 children were reported to have required admission 
to hospital after exposure to a traditional automatic dishwashing product (liquid, 
powder or granular product). One was admitted for 9 days, and 3 esophagoscopies 
were performed as the child had been unable to swallow; the patient was discharged 
for weekly oesophageal dilation. A second child required two esophagoscopies 
during a two-day admission. A third child was transferred to the intensive care unit, 
underwent esophagoscopy, and required follow-up oesophageal dilation. 
Our results are limited by factors inherent to poison centre data. Firstly, the 
data included in this study relate to exposures that were reported voluntarily to the 
UK NPIS. Although it is impossible to quantify accurately the total number of 
exposures occurring in the UK, it is probable the total number is higher than that 
reported here. A second limitation is incomplete data reporting and the lack of follow-
up data until complete recovery. For example, an exact product name was not 
always available to the enquirer, and the circumstances and dose were not always 
known (as the incident was unwitnessed) or disclosed. Thirdly, there may also have 
been selection bias towards less severe cases, as 52.9% of exposures were notified 
to the NPIS by public NHS services. Fourthly, given the relatively small number of 
enquiries from hospitals, it is possible that the clinicians managing the patient did not 
consider it necessary to seek the advice of the NPIS even in more severe cases. 
Finally, although it is true that there may be bias in the reporting of enquiries 
regarding automatic dishwashing products to the UK NPIS, this is likely to be similar 
for both traditional and soluble film tablets. Hence, we believe our conclusions 
remain valid.  
The reasons for the difference in frequency of symptoms after ingestion of 
soluble film tablets and traditional tablets are not known with certainty but may relate 
 
 
to the relative hardness of traditional tablets which children may find difficult to bite. 
In addition, soluble film tablets containing a liquid may result in greater ingestion of 
material. 
 
Conclusions 
Most patients (78.6%) did not develop symptoms after exposure to a traditional 
automatic dishwashing tablet. Of the remaining patients who did develop symptoms, 
all were of a minor nature except in 1 case. Although exposure to both traditional and 
soluble film automatic dishwashing tablets rarely produced clinically significant 
symptoms (PSS ≥ 2), the proportion of patients that became symptomatic following 
ingestion of a traditional tablet was significantly lower than that for soluble film 
tablets. Vomiting occurred significantly (p<0.0001) more frequently amongst patients 
who had ingested a soluble film tablet than a traditional tablet.  
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Table 1. Identity, composition* and number of exposures to traditional automatic  
dishwashing tablets in the study. 
 
Manufacturer Product Name Composition* 
Exposures 
n= 
Reckitt Benckiser Finish™ 5-30% Sodium 
percarbonate 
5-30% Sodium 
carbonate 
30-60% Sodium 
tripolyphosphate 
<5% Sodium 
silicate 
220 
McBride Supermarket  
(own brands) 
1-30% Sodium 
percarbonate 
1-25% Sodium 
carbonate 
30-100% Sodium 
tripolyphosphate 
0-30% Sodium 
silicate 
91 
McBride/Thurn 
Produkte GmbH† 
Supermarket  
(own brands) 
10-25% Sodium 
percarbonate 
10-50% Sodium 
carbonate 
15-30% Sodium 
tripolyphosphate 
0-2.5% Sodium 
silicate 
34 
McBride/Budich 
International† 
Supermarket  
(own brands) 
5-25% Sodium 
percarbonate 
10-25% Sodium 
carbonate 
0-10% Sodium 
silicate 
19 
Dicom-Dali UK 
Limited 
Supermarket  
(own brands) 
0-30% Sodium 
percarbonate 
0-22% Sodium 
carbonate 
30-100% Sodium 
tripolyphosphate 
0-9% Sodium 
silicate 
11 
 
 
Ecover Ecover™ 15-30% Sodium 
percarbonate 
5-15% Sodium 
carbonate 
5-15% Sodium 
silicate 
11 
Thurn Produkte 
GmbH 
Supermarket  
(own brands) 
10-25% Sodium 
percarbonate 
10-50% Sodium 
carbonate 
6 
Budich 
International 
Supermarket  
(own brands) 
5-15% Sodium 
percarbonate 
>20% Sodium 
carbonate 
4 
Chemolux S.à r. l Supermarket  
(own brands) 
5-15% Sodium 
percarbonate 
15-20% Sodium 
carbonate 
4 
Evans Vanodine 
International 
Glaze™ 10-20% Sodium 
percarbonate 
20-25% Sodium 
carbonate 
10-20% Sodium 
silicate 
3 
The London Oil 
Refining Company 
Limited 
Astonish™  5-25% Sodium 
percarbonate 
>25% Sodium 
carbonate 
1-5% Sodium 
silicate 
3 
JohnsonDiversey 
UK Limited 
Bryta™ 15-30% Sodium 
percarbonate 
5-15% Sodium 
carbonate 
5-15% Sodium 
silicate 
2 
WIN Cosmetic 
GmbH & Co. KG 
Supermarket (own 
brands) 
5-15% Sodium 
percarbonate 
15-30% Sodium 
carbonate 
2 
Ecozone Ltd Ecozone™ 15-30% Sodium 
percarbonate 
>30% Sodium 
carbonate 
<5% Sodium 
silicate 
1 
 
 
* The composition of some products has changed over the course of the study, so a 
composite for the manufacturer has been given, which is representative. 
† For 53 of the 411 products (12.9%), two manufacturers are shown as there were 
two manufacturers and two separate safety datasheets pertaining to the same 
product name during the period of the study. 
 
 
 
 
Table 2. Poisoning Severity Score (PSS) [6] following exposure via all routes to 
traditional or soluble film tablets and tablets of an unknown type. 
PSS 
Traditional 
tablets 
(n=487)* 
Soluble film   
tablets 
(n=482)* 
Unknown tablet 
type 
(n=279)* 
n % n % n % 
None   (PPS 0) 383 78.6 325 67.4  198 71.0 
Minor   (PSS 1) 103 21.1 155 32.2    80 28.7 
Moderate  (PSS 2)    1   0.2    2   0.4     1   0.4 
Severe  (PSS 3)    0   0.0    0   0.0     0   0.0 
* Excludes from total the five cases (traditional tablet exposures), six cases (soluble 
film tablet exposures) and seven cases (tablets of unknown type) where features 
were not known. 
 
  
 
 
Table 3. Reported features following ingestion (alone or in conjunction with other 
routes) of either traditional or soluble film tablets. 
Feature 
Traditional tablets 
(n=483)* 
Soluble film tablets 
(n=474)* 
n % n % 
Vomiting   71 14.7 121 25.5 
Nausea    6  1.2    8   1.7 
Skin rash    5   1.0    5   1.0 
Coughing    4   0.8    6   1.3 
Burning sensation in the mouth    2   0.4    0   0.0 
Diarrhea    2   0.4    2   0.4 
Foaming at the mouth    2   0.4    1   0.2 
Pharyngitis    2   0.4    1   0.2 
Taste perversion    2   0.4    0   0.0 
Abdominal pain    1   0.2    2   0.4 
Blistering/ulcer in the mouth    1   0.2    1   0.2 
Cold extremities    1   0.0    0   0.0 
Cyanosis    1   0.2    0   0.0 
Dyspnea    1   0.2    1   0.2 
Increased salivation    1   0.2    0   0.0 
Laryngitis    1   0.2    2   0.4 
Painful swallowing    1   0.2    0   0.0 
Red saliva    1   0.2    0   0.0 
Burns on lips and tongue    1   0.2    0   0.0 
Ulcer on lip    1   0.2    0   0.0 
Swollen lips    1   0.2    0   0.0 
Stomatitis    0   0.0    3   0.6 
Fever    0   0.0    2   0.4 
Mouth bleeding    0   0.0    2   0.4 
Agitation    0   0.0    1   0.2 
Anxiety    0   0.0    1   0.2 
Bronchospasm/wheeze    0   0.0    1   0.2 
Dyspepsia    0   0.0    1   0.2 
Dysphagia    0   0.0    1   0.2 
Eye irritation    0   0.0    1   0.2 
Flatulence    0   0.0    1   0.2 
Hiccup    0   0.0    1   0.2 
Lacrimation    0   0.0    1   0.2 
Lip irritation    0   0.0    1   0.2 
Malaise    0   0.0    1   0.2 
Paresthesia around the mouth    0   0.0    1   0.2 
Stridor    0   0.0    1   0.2 
No features 382 79.3 323 68.1 
 
 
* Excludes from total the four cases (traditional) and five cases (soluble film) where 
features were not known. 
  
 
 
Table 4. Ocular features present following eye contact (alone or in conjunction with 
other routes) with either traditional or soluble film tablets.  
Feature 
Traditional tablets 
(n=4)* 
Soluble film tablets 
(n=10) 
 n % n % 
Eye pain 2 50.0 2 20.0 
Conjunctivitis 0   0.0 3 30.0 
Blurred vision 0   0.0 2 20.0 
Eye irritation 1 25.0 0   0.0 
None 1 25.0 3 30.0 
* Excludes from total one case (traditional tablet) where features were not known. 
 
 
